Improving cancer research through advanced proteomics technologies
Advancing Proteomics Technologies for Cancer Research
This study is exploring new ways to understand cancer better and find better treatments by using advanced technology, and it aims to help patients by discovering new targets for immunotherapy and improving how we treat tumors.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10978094 on NIH RePORTER |
What this research studies
This research focuses on enhancing proteomics technologies to better understand cancer biology and improve treatment options. By utilizing advanced mass spectrometry and innovative methodologies, the project aims to identify novel immunotherapy targets and elucidate mechanisms driving tumor development. The work is conducted at the Herbert Irving Comprehensive Cancer Center, where the team collaborates with various cancer research programs to support advancements in precision oncology and tumor biology. Patients may benefit from the insights gained through this research, which could lead to more effective cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals diagnosed with various types of cancer who are seeking innovative treatment options.
Not a fit: Patients with non-malignant conditions or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective cancer treatments and improved patient outcomes.
How similar studies have performed: Other research has shown success with similar proteomics approaches, indicating a promising avenue for advancing cancer treatment.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Soni, Rajesh Kumar — Columbia University Health Sciences
- Study coordinator: Soni, Rajesh Kumar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.